The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
103641462 10364146 2 F 20160627 20140806 20160705 EXP CA-AMGEN-CANSP2014057750 AMGEN STEPHEN B. SINGH, INGRID A. HARLE.. TAKOTSUBO CARDIOMYOPATHY SECONDARY IN PART TO CANCER-RELATED PAIN CRISIS: A CASE REPORT. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. 2014;48:137 - 142 59.00 YR A F Y 0.00000 20160705 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
103641462 10364146 1 PS XGEVA DENOSUMAB 1 Unknown UNK U 125320 SOLUTION FOR INJECTION
103641462 10364146 2 SS PROLIA DENOSUMAB 1 Subcutaneous UNK U 0 SOLUTION FOR INJECTION
103641462 10364146 3 SS FENTANYL. FENTANYL 1 Intravenous (not otherwise specified) 35 MUG, AS NECESSARY 0 35 UG
103641462 10364146 4 SS GEFITINIB GEFITINIB 1 Unknown UNK 0
103641462 10364146 5 SS HYDROMORPHONE HYDROMORPHONE 1 Oral 15 MG, Q12H 0 15 MG BID
103641462 10364146 6 SS HYDROMORPHONE HYDROMORPHONE 1 Oral 4 MG, Q2H 0 4 MG
103641462 10364146 7 C HYDRALAZINE HYDRALAZINE HYDROCHLORIDE 1 UNK 0
103641462 10364146 8 C METOCLOPRAMIDE. METOCLOPRAMIDE 1 UNK 0
103641462 10364146 9 C NORTRIPTYLINE NORTRIPTYLINE 1 Oral UNK 0
103641462 10364146 10 C ONDANSETRON ONDANSETRON 1 UNK 0
103641462 10364146 11 C CALCIUM CALCIUM 1 UNK 0
103641462 10364146 12 C ERGOCALCIFEROL. ERGOCALCIFEROL 1 UNK 0
103641462 10364146 13 C DALTEPARIN SODIUM DALTEPARIN SODIUM 1 Subcutaneous UNK 0
103641462 10364146 14 C DALTEPARIN SODIUM DALTEPARIN SODIUM 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
103641462 10364146 1 Product used for unknown indication
103641462 10364146 2 Product used for unknown indication
103641462 10364146 3 Product used for unknown indication
103641462 10364146 4 Product used for unknown indication
103641462 10364146 5 Pain
103641462 10364146 7 Blood pressure increased
103641462 10364146 13 Renal vein thrombosis
103641462 10364146 14 Vena cava thrombosis

Outcome of event

Event ID CASEID OUTC COD
103641462 10364146 OT
103641462 10364146 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
103641462 10364146 Acute myocardial infarction
103641462 10364146 Areflexia
103641462 10364146 Arthralgia
103641462 10364146 Back pain
103641462 10364146 Blood pressure increased
103641462 10364146 Cardiac failure congestive
103641462 10364146 Chest pain
103641462 10364146 Confusional state
103641462 10364146 Dyspnoea
103641462 10364146 Muscular weakness
103641462 10364146 Myoclonus
103641462 10364146 Spinal cord compression
103641462 10364146 Stress cardiomyopathy
103641462 10364146 Toxicity to various agents

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found